Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Lucid Diagnostics Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 29 | 1 | 33 | +5 |
| Shares | 2.45M | 25 | 3.31M | +858.4K (+35.0%) |
| Value | $2.00M | $20 | $2.70M | +$700.9K (+35.1%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Lucid Diagnostics Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sargent Investment Group, LLC | 541,500 | $442.4K | 0.07% |
| Citadel Advisors LLC | 119,887 | $98.2K | 0.00% |
| Sunbelt Securities, Inc. | 83,999 | $67.2K | 0.01% |
| Goldman Sachs Group Inc | 63,575 | $52.0K | 0.00% |
| HRT Financial LP | 59,640 | $48.0K | 0.00% |
| Americana Partners, LLC | 26,427 | $21.6K | 0.00% |
| XTX Topco Ltd | 25,322 | $20.7K | 0.00% |
| Two Sigma Securities, LLC | 19,316 | $15.8K | 0.00% |
| Scratch Capital LLC | 11,904 | $9.75K | 0.01% |
| Creative Planning | 11,853 | $9.70K | 0.00% |
| Gotham Asset Management, LLC | 10,443 | – | – |
Sold out (6)
Institutions that held Lucid Diagnostics Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Levin Capital Strategies, L.P. | 66,528 | $54.2K |
| Verition Fund Management LLC | 39,711 | $32.4K |
| Resources Investment Advisors, LLC. | 11,158 | $9.09K |
| UBS Group AG | 2 | $2 |
| Thompson Investment Management, Inc. | 1 | $1 |
| Hantz Financial Services, Inc. | 10 | $0 |
Not filed for Q4 2024 yet (1)
Institutions that held Lucid Diagnostics Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| M&R Capital Management Inc | 25 | $20 |